- March 4, 2021
- 7:00 pm
- Online (U.S. Pacific Time)
Event Time Listed in U.S. Pacific Time. Click Here to Find the Start Time in Your Time Zone.
$20- Suggested Donation
Your donation helps offset the costs of producing events like these, and allows us to offer them for free to those who cannot give at this time. Click the button below to register and donate.
The field of psychedelic-assisted psychotherapy has been growing rapidly in recent years with decriminalization efforts moving forward on local, state, and federal levels. A multitude of clinical research trials is showing promising results of therapies utilizing MDMA, psilocybin, and ketamine as well as other medicines in the treatment of trauma, depression, addiction, end-of-life, and other mental health conditions.
Ketamine was first developed in the 1960s as a surgical anesthetic for humans. In recent years, it was discovered that ketamine also has rapid acting anti-depressant and anti-obsessional properties. Ketamine also induces dissociative and mystical experiences when used in a particular way. In the last few years, there has been a tremendous amount of interest in the use of ketamine for psychiatric indications, psychological work, and psycho-spiritual exploration. An entire new industry has sprung up around ketamine, including new treatment options for psychiatric patients, keen interest from investors, and curiosity from psychedelic explorers.
Join clinician and CIIS professor Gisele Fernandes-Osterhold for a conversation with psychologist Raquel Bennett about the exploding field of therapeutic ketamine.
This event is one in a three-part series of conversations exploring the rapidly growing field of psychedelic-assisted psychotherapy. Click here for series details.
This event is hosted live online. Instructions on how to join will be emailed to you shortly before the event. If you need to request accessibility accommodations, please email firstname.lastname@example.org at least one week prior to the event. For more information click here.
Raquel Bennett, PhD, is a psychologist and ketamine specialist with 19 years of experience in working with ketamine. She is the founder of KRIYA Institute and KRIYA Conference which are both devoted to the use of ketamine in psychiatry and psychotherapy. Dr. Bennett has given hundreds of lectures and trained thousands of practitioners on working with ketamine in clinical practice. She is best known for articulating different approaches to ketamine treatment, and for authoring Ethical Guidelines for Ketamine Clinicians.
Gisele Fernandes-Osterhold is a licensed psychotherapist, clinical supervisor and graduate level psychology professor. Active in the mental health field for 20 years, she has extensive training and clinical experience in trauma-informed psychotherapy, using an integrative approach that is rooted in Somatic, Humanistic-Existential and Transpersonal psychologies. Being an immigrant to the United States and a woman of color, Gisele has developed a profound interest to multicultural issues, which has become one of the main topics of her work. Gisele’s personal approach to healing is rooted in her commitment to embodied spirituality, informed by her practices of yoga, dance and indigenous traditions of her native Brazil. Besides her psychotherapy practice, Gisele serves as core faculty member in the Integral Counseling Psychology program at CIIS, a mentor at the Center for Psychedelic Therapies and Research at CIIS and a clinical supervisor at the Sage Institute.